Cargando…

Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019

BACKGROUND: Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning pathogen in the USA and worldwide. METHODS: To assess the comparative burden of CR vs carbapenem-susceptible (CS) A. baumannii, this retrospective cohort study analyzed data from adult patients in 250 US hospitals from the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pogue, Jason M., Zhou, Yun, Kanakamedala, Hemanth, Cai, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740340/ https://www.ncbi.nlm.nih.gov/pubmed/34991499 http://dx.doi.org/10.1186/s12879-021-07024-4

Ejemplares similares

551. Burden of Illness in Carbapenem-Resistant Acinetobacter baumannii Infections in US Hospitals (2014 to 2018)
por: Pogue, Jason M, et al.
Publicado: (2019)

842. Impact of Active Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in US Hospitals Between 2014 and 2019
por: Pogue, Jason M, et al.
Publicado: (2020)

848. Trends of Carbapenem Resistance in Enterobacterales in the US Between 2015 and 2019
por: Marcella, Stephen, et al.
Publicado: (2020)

1458. Burden of Illness in Patients with Urinary Tract Infections With or Without Bacteremia Caused by Carbapenem-Resistant Gram-Negative Pathogens in US Hospitals (2014 to 2018)
por: Shields, Ryan K, et al.
Publicado: (2019)

Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia
por: Shields, Ryan K., et al.
Publicado: (2021)

Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance
por: Iovleva, Alina, et al.
Publicado: (2022)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
por: Takagi, E.H., et al.
Publicado: (2009)

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
por: Bulens, Sandra N., et al.
Publicado: (2018)

Is Aerosalization a Problem With Carbapenem-Resistant Acinetobacter baumannii in Thailand Hospital?
por: Apisarnthanarak, Anucha, et al.
Publicado: (2016)

Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019
por: Lötsch, Felix, et al.
Publicado: (2020)

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2014)

Fanny pack transmission of carbapenem-resistant Acinetobacter baumannii
por: DelleFave, Amber, et al.
Publicado: (2023)

The Burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 Patients: A Regional Experience
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital
por: Chang, Yaowen, et al.
Publicado: (2015)

An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital
por: Gottesman, Tamar, et al.
Publicado: (2021)

Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?
por: Medioli, Filippo, et al.
Publicado: (2022)

2158. An outbreak of carbapenem-resistant Acinetobacter baumannii at a tertiary hospital in Ethiopia
por: Adbaru, Mulatu G, et al.
Publicado: (2023)

Epidemiological characteristics of carbapenem-resistant Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii in a tertiary referral hospital in Korea
por: Kang, Sollan, et al.
Publicado: (2022)

Molecular Epidemiology of Carbapenem Non-Susceptible Acinetobacter baumannii in France
por: Jeannot, Katy, et al.
Publicado: (2014)

Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii
por: Pagano, Mariana, et al.
Publicado: (2016)

Seasonal Occurrence and Carbapenem Susceptibility of Bovine Acinetobacter baumannii in Germany
por: Klotz, Peter, et al.
Publicado: (2019)

Heterocyclic Diaryliodonium-Based Inhibitors of Carbapenem-Resistant Acinetobacter baumannii
por: Kumari, Pooja, et al.
Publicado: (2023)

Laboratory to Clinical Investigation of Carbapenem Resistant Acinetobacter baumannii Outbreak in a General Hospital
por: Guo-xin, Mo, et al.
Publicado: (2014)

Molecular and Epidemiological Characterization of Carbapenem-Resistant Acinetobacter baumannii in Non-Tertiary Korean Hospitals
por: Park, Sunok, et al.
Publicado: (2013)

Characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from hospitalized patients in Palestine
por: Handal, R, et al.
Publicado: (2015)

Repeated local emergence of carbapenem-resistant Acinetobacter baumannii in a single hospital ward
por: Schultz, Mark B., et al.
Publicado: (2016)

Characterization of Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Hospitalized Patients in Palestine
por: Handal, Regeen, et al.
Publicado: (2017)

548. Carbapenem-Resistant Acinetobacter baumannii Antibiotic Susceptibility Testing and Antibiogram Formation, Connecticut 2017–2019
por: Paranandi, Anu, et al.
Publicado: (2019)

164. Analysis of Adult, Hospitalized Patients With Carbapenem-resistant (CR) Gram-Negative Bloodstream Infections (GN-BSIs) due to Lactose Fermenters (LFs) and Non-lactose Fermenters (NLFs): Is There a Difference in Outcomes?
por: Lodise, Thomas, et al.
Publicado: (2019)

Rapid detection of Acinetobacter baumannii and molecular epidemiology of carbapenem-resistant A. baumannii in two comprehensive hospitals of Beijing, China
por: Li, Puyuan, et al.
Publicado: (2015)

O047: The effect of active surveillance culture of carbapenem resistant Acinetobacter baumannii on the occurrence of carbapenem resistant Acinetobacter baumannii bacteremia in a single intensive care unit
por: Kim, G, et al.
Publicado: (2013)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Editorial Commentary: Polymyxin-Resistant Acinetobacter baumannii: Urgent Action Needed
por: Pogue, Jason M., et al.
Publicado: (2015)

Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii
por: Vashist, Jitendra, et al.
Publicado: (2011)

Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid
por: Nigro, Steven J., et al.
Publicado: (2015)

Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran
por: Farshadzadeh, Zahra, et al.
Publicado: (2015)

Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland
por: Ramette, A., et al.
Publicado: (2018)

Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection
por: Hawkey, Jane, et al.
Publicado: (2018)

Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections
por: Park, Sang-Won
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5tv6tmm5r13c49cbqu8o310cle